77190373 - TIME IS LIFE

Information

• Trademark
• 77190373

• Source

• Serial Number

  77190373

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 35 - Advertising
  • 41 - Education
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  May 25, 2007
  17 years ago

• Transaction Date

  July 22, 2011
  13 years ago

• Status Date

  May 02, 2011
  13 years ago

• Published for Opposition Date

  August 03, 2010
  14 years ago

• Location Date

  September 28, 2010
  14 years ago

• Status Code

  606

• Current Location

  INTENT TO USE SECTION

  Employee Name

  BRADLEY, EVELYN W

• Attorney Docket Number

  S11890

  Attorney Name

  Gary D. Krugman

  Law Office Assigned Location Code

  L50

• Owners

  • PAION DEUTSCHLAND GMBH

Case File Statements

• GS0011: Reagents for scientific or medical research use; diagnostic preparations or reagents for scientific or research use, biochemical reagents for scientific or medical research use; biochemical diagnostic preparations or reagents for scientific or research use; diagnostic reagents for clinical or medical laboratory use
• GS0051: Pharmaceutical preparations, namely, pharmaceutical preparations derived from living organism proteins and peptides for treatment and diagnosis of tumors, cancer, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; pharmaceutical anti-inflammatory preparations; pharmaceutical nutriceutical preparations for the treatment of strokes, neuron damage, thrombotic diseases, tumors, cancer, heart disease including heart failure, circulation disorders, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; blood clotting test kits comprised of medical diagnostic reagents
• GS0101: Laboratory devices for medical and pharmaceutical investigations, namely, portable medical devices for conducting medical diagnostic tests and blood specimen analysis of the human blood clotting system; medical devices, namely, coated catheters, medical stents, surgical implants comprising artificial materials; membranes intended for medical use, namely, filters for dialysis and hemofiltration
• GS0351: Computerized database management, namely, processing data for third parties in the field of drug development
• GS0411: Educational services, namely, providing seminars and workshops in the field of biotechnology, pharmacology, biochemistry, molecular biology, medical procedures, product research and development of medical devices and pharmaceutical preparations, research procedures, protein design diagnostics, molecular diagnostics, proteogenomic profiling, and gendiagnostics
• GS0421: Database development for others; computer programming for others; performing chemical analyses for others; technical consultation in the field of biotechnology; services of a biotechnological laboratory, namely, conducting laboratory research for others in the field of drug research and development; pharmaceutical research consulting, namely, performing pre-clinical studies; performing quality control for others; preparation of expert opinions in the field of chemical engineering, biology, molecular biology, pharmacology, chemistry, bio-technology, bio-chemistry; product research and development of medical devices and pharmaceutical preparations, and molecular diagnostic services of a bio-chemist, namely, product research and development services for others in the area of gene expression analysis, namely, proteogenomic profiling, DNA-sequencing, drug target development and identifying, designing and analyzing therapeutic proteins; diagnostic research services in the field of molecular science, comparative genome analysis, DNA-arrays including DNA-microarrays, creation of nucleic acid libraries, screening of nucleic acid libraries; performance of pre-clinical research namely, conducting and managing pre-clinical trials and studies of pharmaceutical, bio-technology and health care products; biochemical and biotechnological research and development for others, namely, bio-technological research and development regarding medical disease diagnosis and pharmacology, namely, prenatal diagnostic and identification of hereditary factors leading to diseases, identification of genes involved in the formation of cancer, identification of target molecules for cancer treatment; scientific research on and development of medical diagnostic equipment and pharmaceutical preparations and products for the treatment of tumors, cancer, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; scientific and technical consulting for others in the field of medical science and drug research, namely, identifying, designing, and developing drugs, specifically, therapeutic proteins, gene expression analysis, namely, proteogenomic profiling, DNA-sequencing, drug target development, identification and design; medical science research services for others, namely, prenatal diagnostics, molecular diagnostics, comparative genome analysis, DNA-arrays including DNA-microarrays, creating and screening of nucleic acid libraries, identifying hereditary factors leading to diseases, identifying genes involved in the formation of cancer, identification of target molecules for cancer treatment

Case File Event Statements

• 5/2/2011 - 13 years ago

  42 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Type: MAB6

• 5/2/2011 - 13 years ago

  41 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 9/28/2010 - 14 years ago

  40 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 8/3/2010 - 14 years ago

  39 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 8/3/2010 - 14 years ago

  38 - PUBLISHED FOR OPPOSITION Type: PUBO

• 6/29/2010 - 14 years ago

  37 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 6/28/2010 - 14 years ago

  36 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 6/18/2010 - 14 years ago

  35 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 6/18/2010 - 14 years ago

  34 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 6/18/2010 - 14 years ago

  33 - ASSIGNED TO LIE Type: ALIE

• 6/8/2010 - 14 years ago

  32 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 12/9/2009 - 15 years ago

  31 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 12/9/2009 - 15 years ago

  30 - NON-FINAL ACTION E-MAILED Type: GNRT

• 12/9/2009 - 15 years ago

  29 - NON-FINAL ACTION WRITTEN Type: CNRT

• 11/19/2009 - 15 years ago

  28 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 11/19/2009 - 15 years ago

  27 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 11/19/2009 - 15 years ago

  26 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 5/30/2009 - 15 years ago

  25 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 5/30/2009 - 15 years ago

  24 - NON-FINAL ACTION E-MAILED Type: GNRT

• 5/30/2009 - 15 years ago

  23 - NON-FINAL ACTION WRITTEN Type: CNRT

• 5/27/2009 - 15 years ago

  22 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 5/26/2009 - 15 years ago

  21 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 5/26/2009 - 15 years ago

  20 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI

• 4/9/2009 - 15 years ago

  19 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2

• 4/9/2009 - 15 years ago

  18 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI

• 4/9/2009 - 15 years ago

  17 - SUSPENSION INQUIRY WRITTEN Type: CNSI

• 4/6/2009 - 15 years ago

  16 - LIE CHECKED SUSP - TO ATTY FOR ACTION Type: RCCK

• 10/6/2008 - 16 years ago

  15 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 10/6/2008 - 16 years ago

  14 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 10/6/2008 - 16 years ago

  13 - SUSPENSION LETTER WRITTEN Type: CNSL

• 9/22/2008 - 16 years ago

  12 - LIE CHECKED SUSP - TO ATTY FOR ACTION Type: RCCK

• 3/21/2008 - 16 years ago

  11 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC

• 3/20/2008 - 16 years ago

  10 - ASSIGNED TO LIE Type: ALIE

• 9/13/2007 - 17 years ago

  9 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 9/13/2007 - 17 years ago

  8 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 9/13/2007 - 17 years ago

  7 - SUSPENSION LETTER WRITTEN Type: CNSL

• 9/7/2007 - 17 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 9/7/2007 - 17 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 9/7/2007 - 17 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 9/6/2007 - 17 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 8/16/2007 - 17 years ago

  2 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI

• 6/1/2007 - 17 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP